ModivCare (ModivCare) GF Value : $124.69 (As of May. 05, 2024)

View and export this data going back to 2003. Start your Free Trial

What is ModivCare GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
GuruFocus adjustment factor based on the company’s past returns and growth.
Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-05-05), ModivCare's share price is $27.00. ModivCare's GF Value is $124.69. Therefore, ModivCare's Price-to-GF-Value for today is 0.22.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes ModivCare is Possible Value Trap, Think Twice.

ModivCare (NAS:MODV) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations	All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)	Predictable Companies that possibly be Value Traps
Significantly Overvalued	Predictable Companies which are Significantly Overvalued
Modestly Overvalued	Predictable Companies which are Modestly Overvalued
Fairly Valued	Predictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)	Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)	Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

ModivCare's Price-to-GF-Value for today is calculated as

Price-to-GF-Value	=	Share Price	/	GF Value
	=	27.00	/	124.69
	=	0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ModivCare GF Value Related Terms

Thank you for viewing the detailed overview of ModivCare's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

ModivCare (ModivCare) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ModivCare Inc (NAS:MODV) » Definitions » GF Value

Comparable Companies

Traded in Other Exchanges

PRF0:Germany

Address

6900 Layton Avenue, 12th Floor, Denver, CO, USA, 80237

Website

https://www.modivcare.com

ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.

Executives

Barbara Gutierrez	officer: Chief Financial Officer	8950 E. LOWRY BLVD., DENVER CO 80230
L Heath Sampson	officer: Chief Financial Officer	C/O ADVANCED EMISSIONS SOLUTIONS, INC., 9135 S RIDGELINE BLVD STE 200, HIGHLANDS RANCH CO 80129
Coliseum Capital Management, Llc	director, 10 percent owner	105 ROWAYTON AVENUE, ROWAYTON CT 06853
Henry Toledo	officer: Chief People Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Jessica Kral	officer: Chief Information Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Anne E, Bailey	officer: President, Home Division	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Rebecca Orcutt	officer: VP, Chief Accounting Officer	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Brett M. Hickman	officer: Chief Commercial Officer	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Ilias Simpson	officer: President, Transportation	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Jason E Anderson	officer: President of ModivCare Home	6900 LAYTON AVENUE, SUITE 1200, DENVER CO 80237
Grover Wray	officer: Chief Human Resources Officer	DIGITALGLOBE, INC., 1300 WEST 120TH AVENUE, WESTMINSTER CO 80234
Daniel E Greenleaf	director, officer: CEO and President	C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Jonathan B Bush	officer: SVP, GC and Secretary	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Kenneth Shepard	officer: Vice President, CAO	6900 LAYTON AVENUE, 12TH FLOOR, DENVER CO 80237
Stacy Saal	director	4700 SOUTH SYRACUSE STREET, 4TH FLOOR, DENVER CO 80237